Herantis Pharma (OMX: HRTIS)

Last close As at 21/02/2025

EUR1.51

0.02 (1.00%)

Market capitalisation

EUR60m

Herantis Pharma is a Finland-based clinical-stage biotechnology company focused on developing disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases.

Latest Insights

Healthcare | Comment

Herantis (HEL: HRTIS) presents positive Phase Ib update

Healthcare | Non client QV

Herantis Pharma — Potential disease-modifier for PD

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Analyst, Healthcare

Key Management

  • Antti Vuolanto

    CEO

  • Tone Kvåle

    CFO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free